FI853926L - Stabiliserade piroxikaminjektionsloesningar. - Google Patents

Stabiliserade piroxikaminjektionsloesningar.

Info

Publication number
FI853926L
FI853926L FI853926A FI853926A FI853926L FI 853926 L FI853926 L FI 853926L FI 853926 A FI853926 A FI 853926A FI 853926 A FI853926 A FI 853926A FI 853926 L FI853926 L FI 853926L
Authority
FI
Finland
Prior art keywords
solutions
piroxicam
piroxikaminjektionsloesningar
stabilizer
methylglucamine
Prior art date
Application number
FI853926A
Other languages
English (en)
Other versions
FI84315C (fi
FI853926A0 (fi
FI84315B (fi
Inventor
Walter Fries
Original Assignee
Mack Chem Pharm
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mack Chem Pharm filed Critical Mack Chem Pharm
Publication of FI853926A0 publication Critical patent/FI853926A0/fi
Publication of FI853926L publication Critical patent/FI853926L/fi
Application granted granted Critical
Publication of FI84315B publication Critical patent/FI84315B/fi
Publication of FI84315C publication Critical patent/FI84315C/fi

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Molecular Biology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Dermatology (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Organic Chemistry (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Finger-Pressure Massage (AREA)
FI853926A 1984-10-10 1985-10-09 Foerfarande foer framstaellning av en stabil, vattenhaltig, injekterbar piroxikamloesning. FI84315C (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19843437232 DE3437232A1 (de) 1984-10-10 1984-10-10 Stabilisierte injektionsloesungen von piroxicam
DE3437232 1984-10-10

Publications (4)

Publication Number Publication Date
FI853926A0 FI853926A0 (fi) 1985-10-09
FI853926L true FI853926L (fi) 1986-04-11
FI84315B FI84315B (fi) 1991-08-15
FI84315C FI84315C (fi) 1991-11-25

Family

ID=6247603

Family Applications (1)

Application Number Title Priority Date Filing Date
FI853926A FI84315C (fi) 1984-10-10 1985-10-09 Foerfarande foer framstaellning av en stabil, vattenhaltig, injekterbar piroxikamloesning.

Country Status (22)

Country Link
US (1) US4628053A (fi)
EP (1) EP0177870B1 (fi)
JP (1) JPS6191116A (fi)
KR (1) KR890001001B1 (fi)
CN (1) CN85107838B (fi)
AT (1) ATE62416T1 (fi)
AU (1) AU557184B2 (fi)
CA (1) CA1251734A (fi)
DD (1) DD238329A5 (fi)
DE (2) DE3437232A1 (fi)
DK (1) DK165901C (fi)
FI (1) FI84315C (fi)
GR (1) GR852439B (fi)
HU (1) HU195111B (fi)
IE (1) IE58267B1 (fi)
IL (1) IL76624A0 (fi)
NO (1) NO166687C (fi)
NZ (1) NZ213758A (fi)
PH (1) PH23058A (fi)
PT (1) PT81264B (fi)
SU (1) SU1482509A3 (fi)
ZA (1) ZA857783B (fi)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2545910B1 (fr) * 1983-05-11 1988-07-22 Valeo Dispositif pour ameliorer l'efficacite d'un echangeur de chaleur dans un boitier d'une installation de climatisation, et boitier de cette installation
IT1196307B (it) * 1984-10-22 1988-11-16 Chiesi Farma Spa Formulazioni farmaceutiche acquose di piroxicam monoidrato
US5807568A (en) * 1994-12-27 1998-09-15 Mcneil-Ppc, Inc. Enhanced delivery of topical compositions containing flurbiprofen
IT1283252B1 (it) * 1996-03-15 1998-04-16 Pulitzer Italiana Soluzioni di piroxicam iniettabili per via parenterale
WO1998001138A1 (fr) * 1996-07-04 1998-01-15 Nippon Kayaku Kabushiki Kaisha Injections de succinate sodique de methylprednisolone
US6136799A (en) * 1998-04-08 2000-10-24 Abbott Laboratories Cosolvent formulations
US20020035107A1 (en) 2000-06-20 2002-03-21 Stefan Henke Highly concentrated stable meloxicam solutions
DE10030345A1 (de) * 2000-06-20 2002-01-10 Boehringer Ingelheim Vetmed Hochkonzentrierte stabile Meloxicamlösungen
DE10161077A1 (de) 2001-12-12 2003-06-18 Boehringer Ingelheim Vetmed Hochkonzentrierte stabile Meloxicamlösungen zur nadellosen Injektion
US8992980B2 (en) 2002-10-25 2015-03-31 Boehringer Ingelheim Vetmedica Gmbh Water-soluble meloxicam granules
US8314124B2 (en) 2004-02-06 2012-11-20 Active Biotech Ab Crystalline salts of quinoline compounds and methods for preparing them
EP1568369A1 (en) * 2004-02-23 2005-08-31 Boehringer Ingelheim Vetmedica Gmbh Use of meloxicam for the treatment of respiratory diseases in pigs
DE102004021281A1 (de) * 2004-04-29 2005-11-24 Boehringer Ingelheim Vetmedica Gmbh Verwendung von Meloxicam-Formulierungen in der Veterinärmedizin
DE102004030409A1 (de) * 2004-06-23 2006-01-26 Boehringer Ingelheim Vetmedica Gmbh Neue Verwendung von Meloxicam in der Veterinärmedizin
CA2623201A1 (en) * 2005-09-30 2007-04-12 Boehringer Ingelheim Vetmedica Gmbh Pharmaceutical preparation containing meloxicam
CN101291911B (zh) * 2005-10-19 2014-08-13 泰华制药工业有限公司 拉奎尼莫钠晶体及其制备方法
MX2008015808A (es) * 2006-06-12 2009-02-17 Teva Pharma Preparaciones de laquinimod estable.
EP2977049A1 (en) 2007-12-20 2016-01-27 Teva Pharmaceutical Industries, Ltd. Stable laquinimod preparations
JP2012502038A (ja) * 2008-09-03 2012-01-26 テバ ファーマシューティカル インダストリーズ リミティド 免疫機能の２−オキソ−１，２−ジヒドロ−キノリンモジュレーター
JP5359333B2 (ja) * 2009-02-05 2013-12-04 ゼリア新薬工業株式会社 コロソリン酸含有水性液剤
US8598203B2 (en) * 2009-07-30 2013-12-03 Teva Pharmaceutical Industries, Ltd. Treatment of Crohn's disease with laquinimod
PL2467372T3 (pl) * 2009-08-10 2017-04-28 Teva Pharmaceutical Industries Ltd. Leczenie zaburzeń związanych z BDNF z zastosowaniem lakwinimodu
EP2488145B1 (en) 2009-10-12 2024-04-24 Boehringer Ingelheim Vetmedica GmbH Containers for compositions comprising meloxicam
CA2791805A1 (en) 2010-03-03 2011-09-09 Boehringer Ingelheim Vetmedica Gmbh Use of meloxicam for the long-term treatment of musculoskeletal disorders in cats
US20110218191A1 (en) * 2010-03-03 2011-09-08 Boehringer Ingelheim Vetmedica Gmbh Use of meloxicam for the long term-treatment of kidney disorders in cats
DE102010014290A1 (de) * 2010-04-08 2011-10-13 Hans Otto Meyer zu Spelbrink Mittel zur prophylaktischen und therapeutischen Behandlung von Herpes-Infektionen
US9795568B2 (en) 2010-05-05 2017-10-24 Boehringer Ingelheim Vetmedica Gmbh Low concentration meloxicam tablets
EA201490748A1 (ru) 2011-10-12 2014-12-30 Тева Фармасьютикал Индастриз Лтд. Лечение рассеянного склероза комбинацией лахинимода и финголимода
BR112014018485A8 (pt) 2012-02-03 2017-07-11 Teva Pharma Uso de laquinimod para tratar pacientes com a doença de crohn que falharam com a primeira linha de terapia anti-tnf
TW201400117A (zh) 2012-06-05 2014-01-01 Teva Pharma 使用拉喹莫德治療眼發炎疾病
KR20150091077A (ko) 2012-11-07 2015-08-07 테바 파마슈티컬 인더스트리즈 리미티드 라퀴니모드의 아민염
US9233927B2 (en) 2013-03-14 2016-01-12 Teva Pharmaceutical Industries, Ltd. Crystals of laquinimod sodium and improved process for the manufacture thereof
KR101749425B1 (ko) * 2015-11-17 2017-06-22 연세대학교 산학협력단 난용성 약물의 서방형 제제
WO2019032910A1 (en) * 2017-08-09 2019-02-14 Piedmont Animal Health Llc THERAPEUTIC FORMULATIONS AND USES THEREOF

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE629650A (fi) * 1967-05-18 1900-01-01
US3591584A (en) * 1968-08-27 1971-07-06 Pfizer Benzothiazine dioxides
DE2602363C2 (de) * 1976-01-22 1984-04-12 Bayer Ag, 5090 Leverkusen Wäßrige, injizierbare Niclofolan- Formulierungen
DE2756113A1 (de) * 1977-12-16 1979-06-21 Thomae Gmbh Dr K Neue 4-hydroxy-2h-1,2-benzothiazin- 3-carboxamid-1,1-dioxide, verfahren zu ihrer herstellung und diese enthaltende arzneimittel
DE3217315C2 (de) * 1982-05-08 1986-05-22 Gödecke AG, 1000 Berlin Arzneimittelzubereitungen mit einem Gehalt an Oxicam-Derivaten
AT376879B (de) * 1982-10-27 1985-01-10 Gerot Pharmazeutika Verfahren zur herstellung einer injektionsloesung

Also Published As

Publication number Publication date
FI84315C (fi) 1991-11-25
PH23058A (en) 1989-03-27
HUT38541A (en) 1986-06-30
EP0177870B1 (de) 1991-04-10
KR860003013A (ko) 1986-05-19
DK461385A (da) 1986-04-11
DK165901B (da) 1993-02-08
DE3582468D1 (de) 1991-05-16
DK165901C (da) 1993-06-28
JPS6191116A (ja) 1986-05-09
AU4842185A (en) 1986-04-17
PT81264A (en) 1985-11-01
DK461385D0 (da) 1985-10-09
CN85107838A (zh) 1986-07-09
IE852483L (en) 1986-04-10
CN85107838B (zh) 1988-08-24
SU1482509A3 (ru) 1989-05-23
HU195111B (en) 1988-04-28
ATE62416T1 (de) 1991-04-15
NO854011L (no) 1986-04-11
DD238329A5 (de) 1986-08-20
PT81264B (pt) 1988-02-17
KR890001001B1 (ko) 1989-04-18
NZ213758A (en) 1988-07-28
ZA857783B (en) 1987-05-27
CA1251734A (en) 1989-03-28
DE3437232A1 (de) 1986-04-17
EP0177870A2 (de) 1986-04-16
FI853926A0 (fi) 1985-10-09
GR852439B (fi) 1986-02-10
FI84315B (fi) 1991-08-15
NO166687C (no) 1991-09-04
US4628053A (en) 1986-12-09
IL76624A0 (en) 1986-02-28
EP0177870A3 (en) 1987-06-03
IE58267B1 (en) 1993-08-25
JPH03849B2 (fi) 1991-01-09
NO166687B (no) 1991-05-21
AU557184B2 (en) 1986-12-11

Similar Documents

Publication Publication Date Title
FI853926L (fi) Stabiliserade piroxikaminjektionsloesningar.
IT1200589B (it) Derivati naturali attivita farmagologica
DE3688114D1 (de) Inklusionskomplexe von 7-isopropoxy-isoflavon mit cyclodextrinen, verfahren zu deren herstellung und diese inklusionskomplexe enthaltende pharmazeutische praeparate.
DE59009351D1 (de) Neue arylpyridazine, ihre herstellung, verwendung und sie enthaltende arzneimittel.
ES8500738A1 (es) Un procedimiento para la preparacion de una composicion antiinflamatoria topica como unguento en forma de gel
BG100069A (en) Amidine derivatives containing heterocylic groups, their preparation and application
DE59208974D1 (de) Neue pyrazinderivative, ihre herstellung und verwendung
IT1196307B (it) Formulazioni farmaceutiche acquose di piroxicam monoidrato
MA19882A1 (fr) Derives d'acides w-amines, leur preparation et utilisation ainsi que les compositions contenant ces acides.
DE3863859D1 (de) Stabile, injizierbare loesungen von salzen von vincristin.
ATE6148T1 (de) Hexapeptide, deren herstellung, deren anwendung in arzneimitteln und sie enthaltende zusammensetzungen.
IT8522067A0 (it) Derivati di 6-aminometil-furo-(3,4-c)-piridina, loro preparazione e composizioni farmaceutiche contenenti glistessi.
BG95460A (bg) Изохинолинови производни
IT8548444A0 (it) Derivato del piridone dotato di pro prieta' cardiotoniche e composizioni farmaceutiche contenenti detto derivato
MY100229A (en) Topical anti-inflammatory compositions.
DE3672635D1 (de) Esterderivate von 2,2-dimethyl-3-ethenylcyclopropancarbonsaeure, ihre herstellung, ihre verwendung als parasitizide und sie enthaltende zusammensetzungen.
ATE1011T1 (de) 5-fluoruracil-derivate, deren herstellung und ihre pharmazeutischen zusammensetzungen.

Legal Events

Date Code Title Description
MM Patent lapsed
MM Patent lapsed

Owner name: HEINRICH MACK NACHF.